Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

JAMA Neurology Author Interviews - En podkast av JAMA Network - Mandager

Prøv Podimo gratis i hele 60! dager!

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

 Reklame
Podcast artwork

Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

Visit the podcast's native language site